top of page
Search

Qaelon breakthrough leak detection technology with Caresyntax

  • Apr 26, 2025
  • 1 min read

Updated: May 5, 2025


We’re excited to announce a multi-phase partnership with Caresyntax to build the first real-world evidence (RWE) platform for the measurement and clinical management of surgical leaks.


By combining Qaelon Medical's breakthrough leak detection technology with Caresyntax's market-leading expertise, this collaboration will enable Qaelon Medical to quickly establish a new standard of care for surgical leak detection. Together, we’re taking another significant step toward making surgery smarter, safer, and more efficient.



 
 
 

Recent Posts

See All
Bringing Qaelon’s voice to LSI Europe 2025

CEO, Liam J. Burns, will speak at LSI Europe 2025 in London on the panel: “Pre-clinical Perspectives: Navigating the Investor and Regulatory Landscape Before First in Human.”

 
 
 

Comments


Qaelon Primary Logo_Hi Res.png

Note: Qaelon Medical products are currently under development, have not been cleared by the FDA, and are not yet available for commercial sale in the United States or Europe.

Qaelon Medical, IHU, 1 Place de l’Hôpital

67091 Strasbourg, France

Email: yee-ying.douchamps@qaelonmedical.com

  • LinkedIn

© 2026 Qaelon Medical

bottom of page